Yeh, Lipner lead study in JCI Insight

April 7, 2020

Researchers reported the discovery of a potential treatment strategy to reduce resistance to a chemotherapy combination used to treat pancreatic cancer.

Der named AAAS Fellow

November 26, 2019

The American Association for the Advancement of Science has named Channing Der, PhD, the Sarah Graham Kenan Distinguished Professor of Pharmacology and member of the UNC Lineberger Comprehensive Cancer Center, as an AAAS Fellow. The honor recognizes Der’s “distinguished contributions to the field of cancer research through the discovery of RAS in cancer and the … Continued

Pancreatic cancer tumor classification could optimize treatment choices

November 21, 2019

A study from the University of North Carolina Lineberger Comprehensive Cancer Center could help predict resistance to treatments for pancreatic cancer, one of the deadliest cancer types. In Clinical Cancer Research, a journal of the American Association for Cancer Research, researchers led by UNC Lineberger’s Jen Jen Yeh, MD, and Naim Rashid, PhD, reported findings … Continued

Researchers develop method for separating tissue types in tumor samples

October 21, 2019

A dense web of tissue can surround pancreatic cancer tumors, impeding treatment and sometimes acting as a barrier to the tumor’s spread. Researchers want to distinguish cancerous tissue from the surrounding connective tissue and cells known as stroma as well as from immune cells in the tumor’s environment in order to drive personalized treatment strategies. … Continued